FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns treating, preventing, reducing or suppressing urinary incontinence (SUI) in a female subject. That is ensured by administering a compound which is a selective androgen receptor modulator of formula VIII or IX to said subject.
EFFECT: invention provides effective treatment, prevention, reduction or suppression of urine incontinence with a postmenopausal woman's stress.
4 cl, 9 dwg, 4 tbl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
JASMONATE APPLICATION FOR BLADDER FUNCTION DISORDERS TREATMENT | 2011 |
|
RU2623878C2 |
DEVICES, SYSTEMS AND METHODS FOR TRAINING PELVIC FLOOR MUSCLES | 2017 |
|
RU2740730C2 |
COMPOSITION FOR TREATMENT AND/OR PREVENTION OF LOWER URINARY TRACT SYMPTOMS | 2020 |
|
RU2808426C2 |
METHOD FOR PREDICTION OF EFFICACY OF URETHROPEXY BY FREE SYNTHETIC LOOP IN COMBINATION WITH SELF-TISSUE REPAIR OF CYSTOCELE IN POSTMENOPAUSAL WOMEN WITH STRESS URINARY INCONTINENCE | 2024 |
|
RU2821831C1 |
METHOD FOR CORRECTION OF STRESS URINARY INCONTINENCE (VERSIONS) | 2024 |
|
RU2823976C1 |
DERIVATIVES OF ARYL- OR HETEROARYLAZOLYL CARBINOLS FOR TREATING INCONTINENCE OF URINE | 2002 |
|
RU2308268C2 |
METHODS OF TREATING INCONTINENCE ASSOCIATED WITH SEXUAL ACTIVITY | 2012 |
|
RU2578475C2 |
AGENT FOR TREATMENT OF PATIENT WITH ENURESIS | 1994 |
|
RU2152786C2 |
METHOD OF DIAGNOSTICS AND PREDICTION OF DEVELOPMENT OF FUNCTIONAL URINARY INCONTINENCE IN WOMEN | 2009 |
|
RU2408275C2 |
METHOD FOR COMBINED CONSERVATIVE NON-DRUG TREATMENT OF STRESS URINARY INCONTINENCE IN YOUNG WOMEN | 2021 |
|
RU2760618C2 |
Authors
Dates
2019-06-17—Published
2015-10-16—Filed